Stockscreener 앱 받기
3.10
4.03%
0.12
전일 마감가:
$2.98
열려 있는:
$3
하루 거래량:
2,274
Relative Volume:
0.01
시가총액:
$25.04M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-2.82%
1개월 성능:
-27.23%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$3.00
$3.1949
1주일 범위
$2.92
$3.36
52주 변동 폭
$2.74
$8.50
Firefly Neuroscience Inc Stock (AIFF) Company Profile
명칭
Firefly Neuroscience Inc
전화
888-237-6412
주소
1100 MILITARY ROAD, KENMORE
AIFF을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| AIFF | 3.1006 | 25.04M | 0 | 0 | 0 | 0.00 |
| CRM | 329.85 | 309.29B | 36.47B | 5.63B | 11.46B | 1.59 |
| SAP | 233.37 | 271.00B | 36.09B | 2.98B | 7.67B | 5.2918 |
| NOW | 1,032.49 | 209.86B | 10.46B | 1.34B | 3.35B | 7.72 |
| INTU | 664.89 | 180.93B | 16.29B | 2.96B | 4.63B | 8.44 |
| UBER | 70.48 | 146.00B | 41.96B | 4.40B | 5.96B | -0.22 |
Firefly Neuroscience Inc 주식(AIFF)의 최신 뉴스
Bright Minds Biosciences participates in a conference call with Truist - Nasdaq
Firefly Neuroscience Third Quarter 2024 Earnings: US$0.61 loss per share (vs US$0.18 loss in 3Q 2023) - Yahoo Finance
Information Analysis Incorporated : Announces $2,800,000 Equity Financing - Marketscreener.com
Firefly Neuroscience Inc (AIFF) Quarterly 10-Q Report - Quartzy
Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update - The Manila Times
Reklaim Ltd (MYID-X) QuotePress Release - The Globe and Mail
Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update - GlobeNewswire Inc.
4 Biotech Stocks With AI, Machine Learning Prowess - Investing.com
Firefly Neuroscience to Participate in the 8th Annual Florida Capital Event - The Manila Times
Nano Nuclear Energy Inc (NNE-Q) QuotePress Release - The Globe and Mail
Firefly Neuroscience Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Arbor Realty Trust Schedules Third Quarter 2024 Earnings Conference Call - ForexTV.com
Midnight Sun Mining Corp (MDNGF) QuotePress Release - The Globe and Mail
Gold prices fall but record highs remain in sight - Investing.com
United States shares mixed at close of trade; Dow Jones Industrial Average up 0.37% - MSN
Bright Minds and Firefly Neuroscience Renew Collaboration - TipRanks
What's Going On With Bright Minds Biosciences Stock? - Benzinga
Bright Minds, Firefly Neuroscience Shares Rise on Collaboration for Clinical Trial Analysis - MarketWatch
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.37% - MSN
Bright Minds, Firefly Neuroscience to collaborate after BREAKTHROUGH study - TipRanks
Atossa Therapeutics to Participate in Fireside Chat with Karolinska Institute at BIO-EUROPE 2024 to Discuss a Unique Swedish American Collaboration to Prevent Breast Cancer - The Manila Times
Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data - ForexTV.com
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Manhattan Associates (MANH) Stock Dips 1.52% Amid Broader Softwa - GuruFocus.com
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.37% - MSN
Firefly Neuroscience And Bright Minds Advance Phase 1 Study With AI-Driven Data Analysis - Benzinga
Firefly and Bright Minds collaborate on brain health AI - Investing.com India
Dow Jumps 250 Points; U.S. Bancorp Earnings Top Views - Benzinga
US Stocks Mixed; Abbott Reports Better-Than-Expected Q3 Results - MSN
Firefly and Bright Minds collaborate on brain health AI By Investing.com - Investing.com South Africa
Firefly Neuroscience, Bright Minds collaborate to analyze study data on BMB-101 - TipRanks
Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA™ Technology - The Manila Times
Biotech Alert: Searches spiking for these stocks today - TipRanks
Firefly Neuroscience Announces Use of Its Brain Network Analytics Platform in Phase 1 Study of SP-624, the First Potential Treatment Designed for Women with Major Depressive Disorder - The Manila Times
Firefly Neuroscience to Participate in Upcoming October Investor Conferences - EIN News
Arrivo BioVentures Begins Phase 1 Study of SP-624, the First Potential Treatment Specifically for Women with Major Depressive Disorder - Business Wire
Firefly Neuroscience, Zeto Agree To EEG Headset Distribution Deal - MPO-mag
Firefly Neuroscience, Zeto Agree to EEG Headset Distribution Deal - MPO-mag
AIFF stock touches 52-week low at $2.74 amid market challenges - Investing.com Australia
AIFF stock touches 52-week low at $2.74 amid market challenges By Investing.com - Investing.com South Africa
Bright Minds Biosciences announces participation in upcoming scientific conferences and partnering events - StockTitan
AIFF Stock Hits 52-Week Low at $2.99 Amid Market Challenges - Investing.com India
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.62% - Investing.com
Firefly Neuroscience Inc (AIFF) 재무 분석
Firefly Neuroscience Inc (AIFF)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
12.74%
1.15%
자본화:
|
볼륨(24시간):